The Latin America FMD vaccine market size reached US$ 720.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,236.4 Million by 2032, exhibiting a growth rate (CAGR) of 6.01% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 720.0 Million |
Market Forecast in 2032
|
US$ 1,236.4 Million |
Market Growth Rate 2024-2032 | 6.01% |
Food and mouth disease (FMD) is a contagious viral disease affecting a wide range of livestock species, like cattle, buffaloes, pigs and sheep. It is caused by a virus from the Picornaviridae family of the Aphthovirus genus with various immunological serotypes. The FMD vaccination is one of the most crucial tools used to combat the disease that can have a devastating impact on the economy, society, and the environment. In Latin America, several methods of administering the vaccine have been adopted based on local situations and objectives, such as mass vaccination, vaccination for target animal population, ring vaccination around outbreaks, and vaccination at buffer zones.
Latin America represents one of the largest FMD vaccine markets. It is primarily driven by the development and standardization of diagnostic tests in the region. The rising demand for animal care products and the increasing livestock population in the region are acting as other major factors impelling the market growth. As a result, various government initiatives have been undertaken to ensure the implementation of safe healthcare practices for livestock animals and new control benefits to optimize vaccine-based control programs. They are also creating awareness among the masses regarding the need for proper vaccination to fight against FMD. Moreover, Latin American countries, including Venezuela, Colombia, Uruguay, Bolivia, Paraguay, and Ecuador, have undertaken collaborative initiatives to combat the disease in a cost-effective manner for universal welfare. For instance, Brazilian health authorities carried out a joint operation with the Venezuelan government to eradicate the disease in Venezuela. Such initiatives, in turn, are creating a positive outlook for the market further.
IMARC Group provides an analysis of the key trends in each segment of the Latin America FMD vaccine market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on animal type, vaccine type and distribution channel.
Breakup by Animal Type:
Breakup by Vaccine Type:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Segment Coverage | Animal Type, Vaccine Type, Distribution Channel, Country |
Countries Covered | Brazil, Argentina, Others |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |